自拍偷拍区图,久久偷拍高清亚洲,九色这里只有精品偷拍,偷拍无码五区六区精品视频 ,国产av一,二区,99riav大胸,WWW亚洲国产成人,精品国产男人的天堂久久

Font Size: A+AA-
EN
CN
Online Message
Contact Information
One of telephone, mobile phone number, e-mail is required
Contact
Tel
Mobile phone
Email
QQ
WeChat Account
Message
Other additions
Verification code

Our company's Taibo ? Sildenafil Citrate Orally Disintegrating Tablets are approved for marketing

The Taibo? Sildenafil Citrate Orally Disintegrating Tablets (50mg), which is our company's new dosage form and deemed to have passed the consistency evaluation, was recently approved for marketing.

More
  • C&O obtained exclusive sales rights of Flumarin? in China

    On April 28, 2011, C&O announced that it has been authorized by Shionogi & Co., Ltd., a Japanese pharmaceutical company, to be the exclusive distributor of Flumarin?, an antibiotic of oxacephalosporins for injection, in China.

    More
  • C&O obtained manufacturing license for edaravone

    In March 2011, the high standard edaravone raw materials and injection developed by C&O was approved by SFDA. Edaravone is a neuroprotective agent, used to improve neurological symptoms, activities of daily living and functional impairment due to acu

    More
  • Strategic cooperation with Sumitomo Corporation

    Sumitomo became the strategic shareholder with shareholding of 29% held in C&O. C&O Board of Directors has been restructured and Sumitomo Corporation will appoint three directors to the C&O Board.

    More
  • Major scientific and technological projects for “major new drug initiation”

    The Chinese government has recently included four new drug projects being developed by C&O in the major scientific and technological projects for “major new drug initiation”, the first program established by the Chinese government in the 11th Five-Ye

    More
目前在第13頁(yè), 共有17頁(yè), 共有66條記錄 第一頁(yè) 上一頁(yè) 1112131415 下一頁(yè) 最后一頁(yè) 跳轉(zhuǎn)到頁(yè)
Top
  • Service Tel0755-2552 7000
  • Business Tel0755-2552 7386